Open Validation Project · For Research Use

An objective nuclear-state readout from one SVS image.

Tail Status is the first spectral readout we have observed to relate to cancer. Upload an SVS — get Tail Closed or Tail Runaway.

Pathology has long lacked an objective standard: the same slide, read by different doctors, can get different verdicts — that's not any one doctor's fault. NucleoScope computes a reproducible nuclear structural state variable, RSi, and reads Tail Status from it. In the data analyzed so far, this readout has not required separate rules for different species, cancer types, or tissue sites — a pattern still open to independent testing.

Just as the thermometer replaced "feeling a forehead" to judge fever, we hope RSi can become that "thermometer" for pathology — the same reading, no matter who takes it.

Tumor versus non-tumor status has so far been observed to correspond to a single statistical feature of the RSi distribution (Tail Runaway / Tail Closed) — without prior specification of species, tumor type, or tissue site.
NucleoScope measures the Nuclear-State Spectrum. Tail Status (Closed / Runaway) is one readout drawn from that spectrum, not the spectrum itself. The association between Tail Runaway and cancer is the first spectral finding observed in personal data to date — still awaiting independent validation. NucleoScope is not a "Tail detector" or a "cancer detector" — it is a Nuclear-State Spectrometer.
Scientific Positioning

Measurement, observation, and explanation are kept strictly separate

This separation matters: even if a future explanation of why this pattern exists is revised or overturned, that would not, by itself, overturn the reproducible measurement or the observed statistical correspondence.

1

Measurement

We measure the statistical organization of large nuclear populations.

2

Observation

Tumor versus non-tumor status repeatedly corresponds to one statistical feature of the RSi distribution.

3

Open Question

Why do apparently different pathological conditions converge to a similar statistical morphology pattern?

4

Explanation

Not addressed here. The biological mechanism remains an open question for future work.

The novelty is not that nuclear morphology relates to cancer. The novelty is the possibility that one predefined statistical measurement may generalize across pathological contexts without task-specific calibration.
The Core

Instrument · Phenomenon · Validation

1

Measurement instrument

Extracts large-scale nuclear structural variables from SVS images into a statistical distribution and spectrum readout — independent of any pathologist's label, reproducible on the same image.

2

Observed phenomenon

In the data personally analyzed so far, RSi Tail Runaway repeatedly corresponds to cancer samples, across species and tumor types. Known exception: frozen sections.

3

Independent validation

You're invited to use your own SVS data and the free software to reproduce, revise, or falsify this observation.

Head-to-head · QuPath

QuPath stops at the data. NucleoScope continues to the readout.

Both tools segment nuclei from an SVS image and can export per-nucleus CSV measurements. The difference is where the pipeline stops.

QuPath Workflow

SVS ↓ Nucleus segmentation ↓ CSV (nucleus measurements) ↓ Your own analysis ↓ Python / R / MATLAB ↓ You decide

NucleoScope Workflow

SVS ↓ Nucleus segmentation ↓ CSV (nucleus measurements) ↓ Automatic tail analysis ↓ Tail Status ↓ 🟢 Tail Closed / 🔴 Tail Runaway
🟢 Tail Closed — non-cancer-like pattern. 🔴 Tail Runaway — cancer-like pattern. This is a pattern-level research readout, not a clinical diagnosis — see "What it is / What it is not" on the Instrument page.
QuPath stops at CSV. NucleoScope continues to Tail Status.
Head-to-head · AI Cancer Predictor

AI predictors need to know what they're looking at. NucleoScope's readout, so far, doesn't.

Most AI cancer-prediction systems are trained and validated within a specific species, cancer type, and tissue site. Applying them to a new context typically requires new labeled data and retraining. NucleoScope applies the same fixed measurement everywhere.

AI Cancer Predictor

SVS ↓ Which species? Which cancer type? Which tissue site? ↓ Select / train the matching model ↓ Prediction (bounded by that model's training scope)

NucleoScope

SVS ↓ RSi (the same rule, every time) ↓ Tail Status ↓ 🟢 Tail Closed / 🔴 Tail Runaway
In the data analyzed so far, this readout has not required knowing the species, cancer type, or tissue site in advance — a pattern still open to independent testing. AI cancer-prediction systems, by contrast, are typically scoped to a specific species/cancer-type/tissue-site combination during training, and extending them to a new context usually requires new labeled data.
AI needs to know the species, the cancer type, the tissue. NucleoScope's readout, so far, doesn't.
Open Validation

Don't believe us. Test us.

Why download NucleoScope?

1

Direct Readout

SVS → Tail Status. Not just a CSV, not just a distribution — directly, 🟢 Tail Closed / 🔴 Tail Runaway.

2

One Rule

In the data analyzed so far — human, rat, dog, 33 TCGA cancer types, multiple tissue sites — the same RSi / Tail readout process applies. No need to build separate rules for each cancer type.

3

Open Validation

Download the software → use public SVS data → run it yourself → judge whether the result holds. Anyone can verify it independently.

Download. Run. Verify.
This is a hypothesis, not a conclusion: download the software and test it — falsify it or confirm it — with your own data.
SVS image
NucleoScope measurement
Nuclear-state spectrum
Tail readout
Boundary

This is not a theoretical manifesto

What we are NOT saying

  • That we've proven the nature of cancer
  • That we've established a universal rule with no exceptions
  • That any particular mechanism has been confirmed
  • That this can replace a pathologist's diagnosis

What we ARE saying

  • We have a reproducible measurement method
  • We see a recurring pattern in our personal data (known exception: frozen sections)
  • Independent teams are welcome to test it, free of charge